Private Capital Group’s DexCom DXCM Stock Holding History

Private Capital Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$11K	Buy	148 +48	+48%	+$4.38K	0.01%	1018
2022 Q1	$13K	Sell	100 -20	-17%	-$2.19K	﹤0.01%	1177
2021 Q4	$16K	Sell	120 -4	-3%	-$575	﹤0.01%	1124
2021 Q3	$17K	Sell	124 -20	-14%	-$2.52K	﹤0.01%	1142
2021 Q2	$15K	Buy	144 +44	+44%	+$4.22K	﹤0.01%	1202
2021 Q1	$9K	Sell	100 -224	-69%	-$21K	﹤0.01%	1319
2020 Q4	$30K	Hold	324	–	–	0.01%	1014
2020 Q3	$33K	Hold	324	–	–	0.01%	892
2020 Q2	$33K	Hold	324	–	–	0.01%	898
2020 Q1	$22K	Hold	324	–	–	0.01%	976
2019 Q4	$17K	Buy	324 +224	+224%	+$10.6K	﹤0.01%	1160
2019 Q3	$4K	Hold	100	–	–	﹤0.01%	1719
2019 Q2	$2K	Hold	100	–	–	﹤0.01%	1891
2019 Q1	$3K	Hold	100	–	–	﹤0.01%	1795
2018 Q4	$3K	Hold	100	–	–	﹤0.01%	1760
2018 Q3	$3K	Hold	100	–	–	﹤0.01%	1840
2018 Q2	$2K	Hold	100	–	–	﹤0.01%	1892
2018 Q1	$2K	Hold	100	–	–	﹤0.01%	1835
2017 Q4	$1K	Buy	+100	New	+$1.3K	﹤0.01%	1924

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Capital Group's DXCM Position: Q2 2022 in Review

Private Capital Group increased its DexCom (DXCM) stake by 48% in Q2 2022, buying an estimated $4.38K and bringing the position to 148 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #1018.

Private Capital Group first reported a position in DXCM in Q4 2017 and has held it in 19 quarters since. The position peaked at $33K in Q3 2020. 798 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

Private Capital Group held 148 shares of DexCom worth $11K as of Q2 2022.
Private Capital Group bought 48 DexCom shares in Q2 2022, an estimated $4.38K.
DexCom made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #1018 holding.
Private Capital Group first reported a position in DexCom in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's DexCom position peaked at $33K in Q3 2020.
798 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.